“Our hope is that in places where HIV is running rampant, people could use this gel as a preventive measure to stop the initial infection,”
Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown. The finding is an important step toward developing a vaginal gel that may prevent the spread of HIV, the virus that causes AIDS.
“Our hope is that in places where HIV is running rampant, people could use this gel as a preventive measure to stop the initial infection,” says Joshua L. Hood, MD, PhD, a research instructor in medicine.
The study appears in the current issue of Antiviral Therapy.
Bee venom contains a potent toxin called melittin that can poke holes in the protective envelope that surrounds HIV, and other viruses. Large amounts of free melittin can cause a lot of damage. Indeed, in addition to anti-viral therapy, the paper’s senior author, Samuel A. Wickline, MD, the J. Russell Hornsby Professor of Biomedical Sciences, has shown melittin-loaded nanoparticles to be effective in killing tumor cells.
The new study shows that melittin loaded onto these nanoparticles does not harm normal cells. That’s because Hood added protective bumpers to the nanoparticle surface. When the nanoparticles come into contact with normal cells, which are much larger in size, the particles simply bounce off. HIV, on the other hand, is even smaller than the nanoparticle, so HIV fits between the bumpers and makes contact with the surface of the nanoparticle, where the bee toxin awaits.
“Melittin on the nanoparticles fuses with the viral envelope,” Hood says. “The melittin forms little pore-like attack complexes and ruptures the envelope, stripping it off the virus.”
According to Hood, an advantage of this approach is that the nanoparticle attacks an essential part of the virus’ structure. In contrast, most anti-HIV drugs inhibit the virus’s ability to replicate. But this anti-replication strategy does nothing to stop initial infection, and some strains of the virus have found ways around these drugs and reproduce anyway.
“We are attacking an inherent physical property of HIV,” Hood says. “Theoretically, there isn’t any way for the virus to adapt to that. The virus has to have a protective coat, a double-layered membrane that covers the virus.”
Beyond prevention in the form of a vaginal gel, Hood also sees potential for using nanoparticles with melittin as therapy for existing HIV infections, especially those that are drug-resistant. The nanoparticles could be injected intravenously and, in theory, would be able to clear HIV from the blood stream.
“The basic particle that we are using in these experiments was developed many years ago as an artificial blood product,” Hood says. “It didn’t work very well for delivering oxygen, but it circulates safely in the body and gives us a nice platform that we can adapt to fight different kinds of infections.”
Since melittin attacks double-layered membranes indiscriminately, this concept is not limited to HIV. Many viruses, including hepatitis B and C, rely on the same kind of protective envelope and would be vulnerable to melittin-loaded nanoparticles.
While this particular paper does not address contraception, Hood says the gel easily could be adapted to target sperm as well as HIV. But in some cases people may only want the HIV protection.
The Latest Bing News on:
Killing HIV
- AIDS: Homophobic And Moralistic Images Of 1980S Still Haunt Our View Of HIV That Must Changeon August 1, 2022 at 12:26 pm
If you remember the 1980s, you will likely summon up the image of the Grim Reaper or a black tombstone when asked to think about AIDS. Those imag ...
- Head of World Health Organization tells Montreal conference progress on HIV at riskon August 1, 2022 at 11:40 am
The director-general of the World Health Organization told an international AIDS conference in Montreal today that growing inequality could reverse a decade of progress made in the fight against HIV.
- Explained: Fourth Person Cured Of HIV, How It Happened And How Close Are We To Broader HIV Cureon July 29, 2022 at 7:24 pm
A 66-year-old man who had HIV and cancer has become the fourth person in the world to be cured through bone-marrow transplant treatment.
- California man appears cured of HIV after a stem cell transplant, AIDS conference hearson July 29, 2022 at 12:35 pm
A Southern California man appears to be cured of HIV after undergoing a stem cell transplant to treat leukemia, researchers reported this week at the International AIDS Conference in Montreal.
- A Fourth Person Is Effectively 'Cured' of HIV, And It's The Oldest Patient Yeton July 27, 2022 at 5:10 pm
AIDS researchers announced on Wednesday that a fourth person has been "cured" of HIV, but the dangerous procedure for patients also battling cancer may be little comfort for the tens of millions ...
- Patient achieves HIV and blood cancer remission three decades after HIV diagnosison July 27, 2022 at 9:13 am
Known as the City of Hope patient, he is the fourth patient in the world and the oldest to go into long-term remission of HIV without antiretroviral therapy (ART) for over a year after receiving stem ...
- Fourth person 'cured' of HIV after undergoing risky procedure in USon July 27, 2022 at 8:41 am
AIDS researchers announced on Wednesday that a fourth person has been "cured" of HIV, but the dangerous procedure for patients also battling cancer may be little comfort for the tens of millions ...
- Patient achieves HIV and blood cancer remission three decades after HIV diagnosis through stem cell transplant at City of Hopeon July 27, 2022 at 7:01 am
Among those patients, he also had HIV the longest, since 1988, before going into remission for HIV and leukemia. Patient’s case opens up opportunities for older patients living with HIV and a blood ...
- Fourth Person 'Cured' Of HIV, But Is A Less Risky Cure In Sight?on July 27, 2022 at 7:01 am
AIDS researchers announced on Wednesday that a fourth person has been "cured" of HIV, but the dangerous procedure for patients also battling cancer may be little comfort for the tens of millions ...
- Amid protest by HIV patients, health ministry sources say no shortage of ART drugs in stateson July 26, 2022 at 2:10 am
Sources from the union health ministry said that there is adequate stock nationally for around 95% HIV patients in the country, who are on first and second line ARV (antiretroviral) regimens like ...
The Latest Google Headlines on:
Killing HIV
[/vc_column_text]
The Latest Bing News on:
Nanoparticle drug delivery
- Bacterial Microrobots Deliver Drug Payload to Tumorson July 28, 2022 at 12:45 pm
Scientists at the Max Planck Institute for Intelligent Systems in Germany have developed tumor-targeting microrobots using bacteria. The team exploited the tendency of bacteria to naturally gravitate ...
- EU's Project Phoenix is Helping Nanopharmaceuticals Take Flighton July 28, 2022 at 2:48 am
A novel nanomedicine initiative, Project Phoenix, has been funded by the EU’s Horizon2020 Framework Programme, which comprises 11 project partners from academia and industry within Europe.
- Creating a Microrobot to One Day Tackle Canceron July 27, 2022 at 3:44 pm
In this interview, we speak to Birgül Akolpoglu about her latest research into microrobotics and how these biohybrid microrobots could one day be used to tackle cancer.
- Follow the Money: Lipid Nanoparticle Delivery Platform, Regulatory RNA Targeting, Moreon July 26, 2022 at 5:00 pm
ReCode’s lipid nanoparticle delivery platform enables targeted delivery of genetic therapeutics directly to the organs and cells most impacted by disease, offering improved efficacy and potency. With ...
- How Different Cancer Types Respond to Nanoparticle Drug Deliveryon July 22, 2022 at 1:33 am
Study findings could help researchers better tailor their drug-delivery particles to specific types of cancer, or design new particles that take advantage of the biological features of particular ...
- Global Nanotechnology in Drug Delivery market is projected to grow at a CAGR of 18.7% By 2032: Visiongain Reports Ltdon July 21, 2022 at 6:10 pm
Visiongain has published a new report entitled the Nanotechnology in Drug Delivery 2022-2032. It includes profiles of Nanotechnology in Drug Delivery and Forecasts Market Segment by Technology, ...
- Study may help overcome some obstacles to the development of nanoparticle-based drugson July 21, 2022 at 5:28 pm
Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy.
- Scientists identify ‘bottleneck’ in drug delivery pathways in stem cellson July 19, 2022 at 5:00 pm
Researchers show that in certain types of cells, nanoparticles become ‘trapped’ within bubble-like vesicles and so are prevented from reaching their intended target during drug delivery ...
- Stimulus-responsive Macromolecules and Nanoparticles for Cancer Drug Deliveryon July 16, 2022 at 5:00 pm
Summary of drug-delivery vehicles and stimulus-responsive ... accumulation of systemically delivered macromolecules and nanoparticles in tumor tissue. Macromolecular carriers and nanoparticle ...
- What is Nanobiotechnology Used For?on July 12, 2022 at 8:37 am
then investigate the role of lipid nanoparticles in drug delivery. In contrast, a bionanotechnologist might synthesize a functional protein biomachine, then investigate its function and effects. While ...